Thermo Fisher Scientific, Inc. engages in the provision ... Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents ...

Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2024 results on Jan. 30, before market open. See the ...

Thermo Fisher Scientific Inc.’s TMO recent slew of product launches reflects its ongoing commitment to innovation. The company gains early insights into customer needs through its strong partnerships, ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on Rijnberk InvestInsights’ Substack by Daan Rijnberk.

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker discovery Thermo Fisher Scientific Inc. (NYSE ...

Thermo Fisher Scientific has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Applied BioSystems™ TaqPath™ COVID-19 Diagnostic PCR Kit. The Thermo Scientific iCAP MSX ...

Thermo Fisher Scientific Inc. (NYSE: TMO ... We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.